The cost of diabetes-related hospital care to the Southern District Health Board in 2016/17.

Autor:	Coppell KJ; Public Health Physician and Research Associate Professor, Edgar Diabetes and Obesity Research, Department of Medicine, University of Otago, Dunedin., Drabble SJ; Medical Student, Departments of Medicine, and Preventive and Social Medicine, University of Otago, Dunedin., Cochrane JA; General Manager, Surgical Services and Radiology Directorate, Southern District Health Board, Dunedin., Stamm RA; Research Fellow and Science Writer, Department of Medicine, University of Otago, Dunedin., Sullivan TA; Senior Lecturer and Health Economist, Department of Preventive and Social Medicine, University of Otago, Dunedin.
Jazyk:	angličtina
Zdroj:	The New Zealand medical journal [N Z Med J] 2019 Oct 25; Vol. 132 (1504), pp. 35-45. Date of Electronic Publication: 2019 Oct 25.
Abstrakt:	Aim: To estimate the cost of diabetes-related hospital admissions to the Southern District Health Board for the year 2016/17. Methods: Unidentified data with an ICD-10-AM diagnostic code for any type of diabetes were obtained for admissions to Dunedin and Southland Hospitals. Each admission was categorised according to whether the diabetes diagnostic code was listed first, second or subsequently, and by diagnostic group within each of these three categories. The case weight for each admission was multiplied by the 2016/17 cost weight value of NZ$4,824.67. Results: There were 6,994 separate hospital admission events. The total cost was NZ$40,986,618. Admissions where diabetes was the primary, secondary or subsequent diagnosis cost NZ$2,214,172, NZ$8,057,235 and NZ$30,697,210, respectively. More than 80% of admissions were for those aged 55 years and over. Ketoacidosis was the most common primary reason for admission (n=103) among those with type 1 diabetes, costing NZ$349,892. When diabetes was not the primary or secondary diagnosis, the most common primary diagnosis was a circulatory system disease, costing NZ$8,181,324. The mean (SD) cost per admission where the primary diagnosis was coronary artery disease with and without diabetes diagnostic codes was NZ$10,407 ($20,694) and NZ$8,657 ($11,347), respectively. Conclusions: The annual cost of diabetes-related hospital admissions is substantial. Monitoring the cost of diabetes to DHBs should be prioritised, along with implementation of interventions that reduce preventable diabetes-related hospital admissions, and new diabetes cases. Competing Interests: SD and KC report grants from New Zealand Society for the Study of Diabetes during the conduct of the study.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu